BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6444972)

  • 1. Disappearance of the NK effect after explantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures.
    Masucci MG; Klein E; Argov S
    J Immunol; 1980 May; 124(5):2458-63. PubMed ID: 6444972
    [No Abstract]   [Full Text] [Related]  

  • 2. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression.
    López-Botet M; Silva A; Rodríguez J; de Landazuri MO
    J Immunol; 1982 Sep; 129(3):1109-15. PubMed ID: 6213707
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on cytotoxicity generated in human mixed lymphocyte cultures. II. Anti-K562 effectors are distinct from allospecific CTL and can be generated from NK-depleted T cells.
    Seeley JK; Masucci G; Poros A; Klein E; Golub SH
    J Immunol; 1979 Sep; 123(3):1303-11. PubMed ID: 157371
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
    Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells.
    Linnemeyer PA; Pollack SB
    J Immunol; 1993 May; 150(9):3747-54. PubMed ID: 8386202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cultures of human natural killer cells (large granular lymphocytes) and T cells in the presence of interleukin-2-containing conditioned medium.
    Timonen T; Ortaldo JR; Vose BM; Henkart M; Alvarez J; Herberman RB
    J Reticuloendothel Soc; 1983 Jan; 33(1):67-80. PubMed ID: 6601190
    [No Abstract]   [Full Text] [Related]  

  • 10. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
    Atzpodien J; Gulati SC
    Stem Cells; 1993 Nov; 11(6):511-8. PubMed ID: 8111310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM; Zhu HG; Anderer FA
    Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of new investigational drug taxol on oncolytic activity and stimulation of human lymphocytes.
    Chuang LT; Lotzová E; Cook KR; Cristoforoni P; Morris M; Wharton JT
    Gynecol Oncol; 1993 Jun; 49(3):291-8. PubMed ID: 8100207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical localization of multicatalytic protease complex (proteasome) during generation of murine IL-2-activated natural killer (A-NK) cells.
    Nannmark U; Kitson RP; Johansson BR; Rivett AJ; Goldfarb RH
    Eur J Cell Biol; 1996 Dec; 71(4):402-8. PubMed ID: 8980912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the effect of lentinan on human immune system. II. In vivo effect on NK activity, MLR induced killer activity and PHA induced blastic response of lymphocytes in cancer patients].
    Amino M; Noguchi R; Yata J; Matsumura J; Hirayama R; Abe O; Enomoto K; Asato Y
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2000-6. PubMed ID: 6225393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonally restricted natural killer-like cytotoxicity displayed by cloned human T cell lines.
    Pawelec GP; Hadam MR; Schneider EM; Wernet P
    J Immunol; 1982 Nov; 129(5):2271-6. PubMed ID: 6181165
    [No Abstract]   [Full Text] [Related]  

  • 17. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM; Bonnard GD
    J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity.
    Brunson KW; Ohashi M; Miller CA; Kitson RP; Basse PH; Goldfarb RH
    In Vivo; 1994; 8(1):71-5. PubMed ID: 8054514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
    Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
    Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.